Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 108 (3) , 449-454
- https://doi.org/10.1067/mai.2001.117591
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Tear and conjunctival changes during the allergen-induced early- and late-phase responsesJournal of Allergy and Clinical Immunology, 2000
- Allergic eye disease mechanismsBritish Journal of Ophthalmology, 1998
- Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltrationClinical and Experimental Allergy, 1997
- Effects of nedocromil sodium on airway neurogenic mechanismsJournal of Allergy and Clinical Immunology, 1996
- LevocabastineDrugs, 1995
- Inhibitory effect of levocabastine on allergen‐induced increase of nasal reactivity to histamine and cell influxAllergy, 1993
- Nedocromil SodiumDrugs, 1993
- The effect of nedocromil sodium on the isolated rabbit vagus nerveEuropean Journal of Pharmacology, 1992
- LevocabastineDrugs, 1991
- Inflammatory mediator release on conjunctival provocation of allergic subjects with allergenJournal of Allergy and Clinical Immunology, 1990